ARCHIVES

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997

Beckman Coulter Offers Immunoassay System.

July 27, 2001

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990

More RFPs For Smoking/Health Projects Planned For Release As Subcontracts For Enviro Control

March 14, 1975